Highbridge Capital Management LLC Haemonetics Corp Transaction History

Highbridge Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $1.66 Million - $2.12 Million	-18,508 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $1.32 Million - $1.77 Million	18,508 New	18,508 $1.66 Million
Q4 2017 Feb 14, 2018	SELL	$44.96 - $58.99 $444,879 - $583,706	-9,895 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$40.38 - $44.87 $143,712 - $159,692	-3,559 Reduced 26.45%	9,895 $444,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,454	13,454 $532,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.36B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.